Scientists Developed a System of Organoids That Can Model Activity in B Cells

Centralized Sequencing Program Featured Research

Immune System Information for Researchers

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.

Support for Research

Resources for Researchers

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for immune system researchers.

Connect with Other Researchers

Programs and Networks

See a full list of NIAID-supported programs and networks that further immune system research.

Adams Research Group

The Adams Research Group uses molecular and cellular techniques to manipulate spirochetes, sequence bacterial transcriptomes, characterize cellular processes, map regulatory networks, and study spirochetes during infection.

Short Title
Adams Research Group
Person List Page Type

Philip P. Adams, Ph.D.

Chief, Biology of Spirochetes Unit
Stadtman Tenure-Track Investigator
NIH Distinguished Scholar

Contact: philip.adams@nih.gov

Education:

Ph.D., 2017, Biomedical Sciences, University of Central Florida, FL
B.S., 2012, Biology, Summa Cum Laude, West Virginia Wesleyan College, WV

Dr. Philip Adams earned his undergraduate degree in biology at West Virginia Wesleyan College in 2012, where he first studied B. burgdorferi cell biology. He went on to earn a Ph.D. in biomedical sciences from the University of Central Florida, College of Medicine, Division of Immunity and Pathogenesis in 2017. His dissertation work identified and characterized murine infection-relevant RNAs in...

Learn more about Philip P. Adams, Ph.D.

Headshot of Philip P. Adams, Ph.D.

Erika Smith, Ph.D.

Postdoctoral Fellow

Contact: erika.smith2@nih.gov

Education:

Ph.D., Johns Hopkins University School of Medicine
B.A., Colby College

Dr. Erika Smith earned her undergraduate degree in biochemistry from Colby College in 2018, where she studied carotenoid biosynthesis in the archaeon Haloferax volcanii. In 2024, she earned her Ph.D. in biochemistry, cellular, and molecular biology at the Johns Hopkins School of Medicine as a member of Dr. Erin Goley’s laboratory. Her thesis work involved characterizing mechanisms of adaptation to...

Learn more about Erika Smith, Ph.D.

Headshot of Erika Smith

Max Freedman, B.S.

Postbaccalaureate Fellow

Contact: robert.freedman2@nih.gov

Education:

B.S., Vassar College

Max Freedman graduated from Vassar College in 2024 with a B.A. in biology and science & technology in society (STS). In his undergraduate research, Max characterized the role of eukaryotic initiation factor 3 (eIF3) in translation initiation. Max joined BOSU in July 2024 to investigate regulatory RNAs in spirochetes.

Learn more about Max Freedman, B.S.

Headshot of Max Freedman

Julia Silberman, B.S.

Postbaccalaureate Fellow

Contact: julia.silberman@nih.gov

Education:

B.S., Tufts University

Julia Silberman graduated from Tufts University in 2023 with a B.S. in biochemistry. In her undergraduate research, Julia examined inhibition of intein-splicing as a prospective antimicrobial strategy. Julia joined BOSU in June 2023 to investigate the cell biology of spirochetes.

Learn more about Julia Silberman, B.S.

Headshot of Julia Silberman
Photo of Dr. Philip Adams Research Group Members in Summer 2024.

Adams Lab: Group on Gene Regulation in Bacterial Pathogens, NICHD, Summer 2024. Left to right: Julia Silberman, Postbaccalaureate Fellow; Haden Fincham, Summer Intern; Philip Adams, NIH Independent Research Scholar; Ryan Fishman, Postbaccalaureate Fellow; Max Freedman, Postbaccalaureate Fellow.

Credit: NICHD
Photo of Dr. Philip Adams Research Group Members in Summer 2023

Hiking at Harpers Ferry, West Virginia. Adams Lab: Group on Gene Regulation in Bacterial Pathogens, NICHD, Summer 2023. Left to right: Julia Silberman, Postbaccalaureate Fellow; Daniel Soliman, Postbaccalaureate Fellow; Philip Adams, NIH Independent Research Scholar; Ryan Fishman, Postbaccalaureate Fellow.

Credit: NICHD
Photo of Dr. Philip Adams Research Group Members in Summer 2022.

Hiking at Sugarloaf Mountain, Maryland. Adams Lab: Group on Gene Regulation in Bacterial Pathogens, NICHD, Summer 2022. Top row, left to right: Emily Petroni, Postbaccalaureate Fellow; Philip Adams, NIH Independent Research Scholar; Maxime Zamba-Campero, Postbaccalaureate Fellow; Daniel Tetreault, Postbaccalaureate Fellow; bottom row: Daniel Soliman, Postbaccalaureate Fellow.

Credit: NICHD
Photo of Dr. Philip Adams Research Group Members in Summer 2021.

Adams Lab: Group on Gene Regulation in Bacterial Pathogens, NICHD, Summer 2021. Left to right: Daniel Tetreault, Postbaccalaureate Fellow; Philip Adams, NIH Independent Research Scholar; Maxime Zamba-Campero, Postbaccalaureate Fellow.

Credit: NICHD

Former Research Group Members

  • Ryan Fishman, Postbaccalaureate Fellow 2023-2024, Current Position: Medical Student, Duke University, School of Medicine
  • Daniel Soliman, Postbaccalaureate Fellow 2022-2023, Current Position: Medical Student, Washington University in St. Louis, School of Medicine
  • Emily Petroni, Postbaccalaureate Fellow 2021-2023, Current Position: Medical Student, Vanderbilt University, School of Medicine
  • Daniel Tetreault, Postbaccalaureate Fellow 2020-2022, Current Position: PhD Student, Cornell University, Microbiology
  • Maxime Zamba-Campero, Postbaccalaureate Fellow 2019-2021, Current Position: PhD Student, University of Pennsylvania, Cell and Molecular Biology

Former Summer Interns

  • Haden Fincham, Summer 2024, Current Position: Undergraduate Student, West Virginia Wesleyan College
  • Raghib Nihal, Summer 2022, Current Position: Medical Student, University of Virginia, School of Medicine
Section
Content Manager
Content Coordinator
December 17, 2024

HIV Research Enterprise Webinar Recordings

Moutsopoulos Research Group

Short Title
Moutsopoulos Research Group
Person List Page Type

Niki M. Moutsopoulos, D.D.S., Ph.D.

Chief, Laboratory of Host Immunity and Microbiome
Chief, Human Barrier Immunity Section

Provides direct clinical care to patients at NIH Clinical Center

Education:

D.D.S., Aristotle University of Thessaloniki, Greece 
Ph.D., University of Maryland Baltimore/National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD

Dr. Moutsopoulos received a D.D.S. degree from the Aristotle University of Thessaloniki, Greece, completed her specialization in periodontology at the University of Maryland, and obtained a Ph.D. in immunology from the University of Maryland while working in the laboratory of Dr. Sharon Wahl at the NIH National Institute of Dental and Craniofacial Research. Following her Ph.D., she remained at NIH...

Learn more about Niki M. Moutsopoulos, D.D.S., Ph.D.

Headshot of Niki M. Moutsopoulos, D.D.S., Ph.D.
Section
Content Coordinator
November 14, 2024

Vector Biology Meetings and Workshops

HIV Research Enterprise Blog Series

Learn more about the HIV/AIDS clinical trials networks and the network refinement process with the resources and information available on this site. The following resources on HIV scientific and operational priorities published in the NIAID Now blog may be of particular interest.

NIAID Program Outlines Best Practices for Reporting H5N1 Influenza Sequence Data

Data Science Dispatch |

Data sharing is a crucial part of responding to infectious disease outbreaks. Timely access to comprehensive data enables researchers and policymakers to take action to mitigate the threat posed by emerging infectious diseases.

As part of NIAID’s public health mission, the institute supports research programs, repositories, and resources that generate and share data and develops policies that facilitate data coordination and sharing to support infectious disease response and countermeasures.

Gathering and sharing data has been a key part of the response to the highly pathogenic avian influenza (HPAI) outbreak. HPAI is caused by the H5N1 virus. Since 2003, H5N1 influenza viruses have circulated in 23 countries, primarily affecting wild birds and poultry. In that time there have been nearly 900 reported human cases, primarily among people who have had close contact with infected birds.

The recent HPAI H5N1 outbreak has spread from birds to infect more than 50 animal species. In March 2024, an HPAI H5N1 outbreak was reported among dairy cows in Texas. As of October 28, H5N1 has been reported in dairy cow populations in 14 states, and 34 human cases have been reported in the United States during 2024. So far, the virus has not shown genetic evidence of acquiring the ability to spread from person to person.

Public health officials from NIAID, the National Institutes of Health (NIH), the U.S. Department of Agriculture (USDA), and the Centers for Disease Control and Prevention (CDC) are closely monitoring the outbreak as part of overarching pandemic preparedness efforts.

Setting the agenda for H5N1 research

In May, NIAID released an H5N1 Influenza research agenda outlining a strategy to understand H5N1 biology and objectives to advance detection, treatment, and prevention. The agenda mobilized various NIAID programs to provide scientific and data support, including: 

The research agenda highlights the importance of studies to understand how H5N1 virus is spreading within and between farms. The scientific community is generating phylogenetic trees using the most recent viral isolates available in GenBank, the publicly available NIH database of annotated genetic sequences. Investigators are also leveraging open-source tools, such as Nextstrain, for real-time analysis of H5N1 sequences to monitor for potential changes in pathogenesis and compatibility to vaccines, therapeutics, and diagnostics.

Best practices for sharing H5N1 data

Guidelines for sharing data from the bovine H5N1 outbreak through the CEIRR network.

Guidelines for sharing data from the bovine H5N1 outbreak through the CEIRR network.

Credit: Centers of Excellence for Influenza Research and Response (CEIRR)

To support clear and consistent data sharing in the ongoing bovine H5N1 outbreak, Centers of Excellence for Influenza Research and Response (CEIRR) prepared a set of best practice guidelines for the appropriate collection and sharing of data from viral isolate samples related to the outbreak. CEIRR is an NIAID-funded research network that studies the natural history, transmission, and pathogenesis of influenza and provides research infrastructure to address influenza outbreaks. 

The best practices for collecting and sharing data from retail milk and other associated HPAI H5 samples include using a centralized repository, applying standardized metadata templates and consistent H5N1 sequence nomenclature, and rapidly reporting sensitive results.

The CEIRR best practices align with NIAID and NIH data sharing policies, leverage public data repositories, and are tailored to meet the needs of an evolving public health concern. They also establish the data sharing infrastructure for identifying and containing H5N1 in the event that it spreads from human to human.

“The CEIRR program created these guidelines because the sampling of retail food products for evidence of viral contamination is not something that has traditionally occurred in the influenza field," explained Dr. Erik Stemmy, Ph.D., CEIRR team lead and NIAID Respiratory Diseases Branch Deputy Chief. "Because there was not an established process to report this information and share it, we wanted to ensure that the CEIRR investigators were standardized and recommend that other researchers use this format as much as possible so that data can be shared and interpreted more easily.”

Learn more about how NIAID is advancing H5N1 research: 

New Anthrax Vaccine with Faster Protection

The U.S. Food and Drug Administration (FDA) licensed CYFENDUS™, a novel anthrax vaccine developed with extensive support from NIAID and federal collaborators. Also known as AV7909 the two-dose vaccine offers faster protection than the previously approved three-dose anthrax vaccine, BioThrax. The licensure is an important step by the U.S. Government to prepare for intentional or naturally occurring biothreats.